Short Interest Update on ICON plc (ICLR)

ICON plc (ICLR) : 5 days before expiry, shorts in ICON plc (ICLR) have reduced from 2,018,754 on Jul 29, 2016, to 1,884,724 on August 15, 2016. On an average, 389,544 shares are traded on the exchange. The outstanding bearish positions are equal to 3.5% of the float. Short sellers have covered -134,030 shares, a reduction of -6.6%, which underlines that they dont expect the stock to fall further from the current levels. The short interest information was released on Wednesday Aug 24th after the market close.

ICON plc (NASDAQ:ICLR): The stock opened at $76.67 on Wednesday but the bulls could not build on the opening and the stock topped out at $77.29 for the day. The stock traded down to $74.83 during the day, due to lack of any buying support eventually closed down at $75.02 with a loss of -2.48% for the day. The stock had closed at $76.93 on the previous day. The total traded volume was 344,258 shares.


ICON public limited company (ICON) is an Ireland-based contract research organization (CRO), providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. ICONs services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. ICON also conducts various laboratory tests on the patients blood, urine and other bodily fluids at appropriate intervals during the trial. The Companys information systems offerings include ICONIK, Firecrest, iDOC, iLearn, ADDPLAN, AptivAdvantage and AptivInsite. ICON, through its subsidiaries, also provides payer-validated market access solutions, and clinical trial consulting and regulatory support.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.